应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
GLYC GlycoMimetics Inc.
休市中 05-31 16:00:00 EDT
0.2710
-0.0030
-1.09%
盘后
0.2779
+0.0069
+2.55%
19:18 EDT
最高
0.2800
最低
0.2703
成交量
39.69万
今开
0.2720
昨收
0.2740
日振幅
3.54%
总市值
1,747万
流通市值
1,097万
总股本
6,445万
成交额
10.88万
换手率
0.98%
流通股本
4,047万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Glycomimetics, Inc.盘中异动 早盘大幅上涨5.26%
自选股智能写手 · 05-30 22:31
Glycomimetics, Inc.盘中异动 早盘大幅上涨5.26%
Glycomimetics, Inc.2024财年第一财季实现净利润-10.74百万美元,同比减少3.67%
自选股智能写手 · 05-18
Glycomimetics, Inc.2024财年第一财季实现净利润-10.74百万美元,同比减少3.67%
Glycomimetics, Inc.盘中异动 早盘股价大跌5.54%报0.282美元
自选股智能写手 · 05-10
Glycomimetics, Inc.盘中异动 早盘股价大跌5.54%报0.282美元
GlycoMimetics Inc 预计每股亏损 16 美分 - 财报前瞻
Reuters · 05-08
GlycoMimetics Inc 预计每股亏损 16 美分 - 财报前瞻
Glycomimetics, Inc.盘中异动 股价大跌5.23%报0.299美元
自选股智能写手 · 05-07
Glycomimetics, Inc.盘中异动 股价大跌5.23%报0.299美元
美国研究综述-ServiceNow、Ulta Beauty、Vertex Pharmaceuticals
Reuters · 05-07
美国研究综述-ServiceNow、Ulta Beauty、Vertex Pharmaceuticals
Glycomimetics, Inc.盘中异动 股价大涨5.56%
自选股智能写手 · 05-02
Glycomimetics, Inc.盘中异动 股价大涨5.56%
Glycomimetics, Inc.盘中异动 大幅上涨5.18%
自选股智能写手 · 04-29
Glycomimetics, Inc.盘中异动 大幅上涨5.18%
Glycomimetics, Inc.盘中异动 早盘大幅上涨5.37%
自选股智能写手 · 04-22
Glycomimetics, Inc.盘中异动 早盘大幅上涨5.37%
Glycomimetics, Inc.盘中异动 下午盘大幅跳水5.04%报2.17美元
自选股智能写手 · 04-19
Glycomimetics, Inc.盘中异动 下午盘大幅跳水5.04%报2.17美元
Glycomimetics, Inc.盘中异动 急速下挫5.10%报2.14美元
自选股智能写手 · 04-17
Glycomimetics, Inc.盘中异动 急速下挫5.10%报2.14美元
Glycomimetics, Inc.盘中异动 下午盘急速跳水5.00%报2.28美元
自选股智能写手 · 04-16
Glycomimetics, Inc.盘中异动 下午盘急速跳水5.00%报2.28美元
公司概况
公司名称:
GlycoMimetics Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Glycomimetics, Inc.作为一家临床生物科技公司,致力于发现并开发新型拟糖物药物以解决某些疾病引起的未曾遇到的医疗需求,而碳水化合物生物技术在此类疾病中扮演关键角色。拟糖物是一簇分子,这些分子能够模仿重要生物程序中碳水化合物的结构。利用其在碳水化合物化学及碳水化合物生物领域的专业知识,公司正在开发一系列其自主所有的拟糖物,这些拟糖物能够抑制碳水化合物疾病化的功能,如在炎症反应,癌症以及传染病中的功能。公司相信这代表药物发现以治疗众多疾病的一个创新性方法。公司2003年4月4日注册成立并于2003年5月21日开始运营。公司总部设在马里兰州的盖瑟斯堡。
发行价格:
--
{"stockData":{"symbol":"GLYC","market":"US","secType":"STK","nameCN":"GlycoMimetics Inc.","latestPrice":0.271,"timestamp":1717185600000,"preClose":0.274,"halted":0,"volume":396856,"hourTrading":{"tag":"盘后","latestPrice":0.2779,"preClose":0.271,"latestTime":"19:18 EDT","volume":8809,"amount":2435.9217,"timestamp":1717197532314},"delay":0,"floatShares":40465611,"shares":64450835,"eps":-0.584093,"marketStatus":"休市中","marketStatusCode":7,"change":-0.003,"latestTime":"05-31 16:00:00 EDT","open":0.272,"high":0.28,"low":0.2703,"amount":108830.4360068,"amplitude":0.035401,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.584093,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1717401600000},"adr":0,"listingDate":1389330000000,"adjPreClose":0.274,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":0.2766,"preClose":0.274,"latestTime":"09:27 EDT","volume":13734,"amount":3765.3134400000004,"timestamp":1717162030380},"postHourTrading":{"tag":"盘后","latestPrice":0.2779,"preClose":0.271,"latestTime":"19:18 EDT","volume":8809,"amount":2435.9217,"timestamp":1717197532314},"volumeRatio":0.4341831604097779},"requestUrl":"/m/hq/s/GLYC/wiki","defaultTab":"wiki","newsList":[{"id":"2439625314","title":"Glycomimetics, Inc.盘中异动 早盘大幅上涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439625314","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2439625314?lang=zh_cn&edition=full","pubTime":"2024-05-30 22:31","pubTimestamp":1717079510,"startTime":"0","endTime":"0","summary":"北京时间2024年05月30日22时31分,Glycomimetics, Inc.股票出现异动,股价大幅上涨5.26%。截至发稿,该股报0.270美元/股,成交量21.2877万股,换手率0.33%,振幅3.12%。Glycomimetics, Inc.股票所在的生物技术行业中,整体跌幅为0.03%。其相关个股中,Nkgen Biotech Inc C/Wts 31/05/2028、Calidi Biotherapeutics, Inc.、Humacyte Inc C/Wts 27/08/2026 涨幅较大,Kintara Therapeutics, Inc.、Mustang Bio, Inc.、Onconetix, Inc.较为活跃,换手率分别为86.94%、50.99%、46.15%,振幅较大的相关个股有Kintara Therapeutics, Inc.、Calidi Biotherapeutics, Inc.、Onconetix, Inc.,振幅分别为51.32%、31.10%、29.16%。Glycomimetics, Inc.公司简介:GlycoMimetics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530223150af8b2a96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530223150af8b2a96&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2436794650","title":"Glycomimetics, Inc.2024财年第一财季实现净利润-10.74百万美元,同比减少3.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436794650","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2436794650?lang=zh_cn&edition=full","pubTime":"2024-05-18 00:24","pubTimestamp":1715963080,"startTime":"0","endTime":"0","summary":"3月31日,Glycomimetics, Inc.公布财报,公告显示公司2024财年第一财季净利润为-10.74百万美元,同比减少3.67%;其中营业收入为0.00美元,每股基本收益为-0.17美元。从资产负债表来看,Glycomimetics, Inc.总负债5.29百万美元,其中短期债务630827.00美元,资产负债比为6.47,流动比率为6.29。机构评级:截至2024年3月31日,当前有2家机构对Glycomimetics, Inc.目标价做出预测,其中目标均价为0.75美元,其中最低目标价为0.50美元,最高目标价为1.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405180024488b131cba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405180024488b131cba&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434517228","title":"Glycomimetics, Inc.盘中异动 早盘股价大跌5.54%报0.282美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434517228","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434517228?lang=zh_cn&edition=full","pubTime":"2024-05-10 21:31","pubTimestamp":1715347867,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日21时31分,Glycomimetics, Inc.股票出现波动,股价快速跳水5.54%。截至发稿,该股报0.282美元/股,成交量44.7389万股,换手率0.69%,振幅1.21%。Glycomimetics, Inc.股票所在的生物技术行业中,整体涨幅为0.15%。Glycomimetics, Inc.公司简介:GlycoMimetics Inc是一家临床阶段的生物技术公司。消息层面,截至21时31分,《HC Wainwright & Co.:下调GlycoMimetics评级,由买入调整至中性评级。》资讯为影响Glycomimetics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102131088750f5b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102131088750f5b1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433736374","title":"GlycoMimetics Inc 预计每股亏损 16 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433736374","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433736374?lang=zh_cn&edition=full","pubTime":"2024-05-08 02:28","pubTimestamp":1715106509,"startTime":"0","endTime":"0","summary":" * GlycoMimetics Inc 将于5月9日公布截至2024年3月31日的财报,预计该公司的季度收入将保持不变。* * LSEG 的分析师平均预计 GlycoMimetics Inc 每股亏损 16 美分。* 华尔街对 GlycoMimetics 公司 12 个月目标价的中位数为 0.75 美元,高于上一交易日 0.32 美元的收盘价。5月7日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2433830397","title":"Glycomimetics, Inc.盘中异动 股价大跌5.23%报0.299美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433830397","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433830397?lang=zh_cn&edition=full","pubTime":"2024-05-07 22:04","pubTimestamp":1715090694,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日22时04分,Glycomimetics, Inc.股票出现波动,股价大幅下跌5.23%。截至发稿,该股报0.299美元/股,成交量233.769万股,换手率3.63%,振幅8.62%。Glycomimetics, Inc.股票所在的生物技术行业中,整体涨幅为0.72%。Glycomimetics, Inc.公司简介:GlycoMimetics Inc是一家临床阶段的生物技术公司。消息层面,截至22时04分,《HC Wainwright & Co.:下调GlycoMimetics评级,由买入调整至中性评级。》资讯为影响Glycomimetics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050722045479264c6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050722045479264c6c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433724078","title":"美国研究综述-ServiceNow、Ulta Beauty、Vertex Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2433724078","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433724078?lang=zh_cn&edition=full","pubTime":"2024-05-07 16:20","pubTimestamp":1715070052,"startTime":"0","endTime":"0","summary":" 路透5月7日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价,其中包括 ServiceNow、Ulta Beauty 和 Vertex Pharmaceuticals。要闻 * 艾睿电子 :雷蒙德-詹姆斯将目标价从130美元上调至135美元 * Cardinal Health Inc :杰富瑞将目标价从110美元下调至105美元 * ServiceNow Inc :贝雅将目标价从870美元上调至885美元 * Ulta Beauty Inc :奥本海默将目标价从500美元下调至475美元 * Vertex Pharmaceuticals Inc :Piper Sandler将目标价从450美元上调至456美元 以下是路透周二报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432046856","title":"Glycomimetics, Inc.盘中异动 股价大涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432046856","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432046856?lang=zh_cn&edition=full","pubTime":"2024-05-02 21:41","pubTimestamp":1714657318,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日21时41分,Glycomimetics, Inc.股票出现波动,股价急速拉升5.56%。截至发稿,该股报1.71美元/股,成交量5.5588万股,换手率0.09%,振幅1.23%。Glycomimetics, Inc.股票所在的生物技术行业中,整体跌幅为0.30%。其相关个股中,Allarity Therapeutics, Inc.、Context Therapeutics Inc.、Aptevo Therapeutics Inc.涨幅较大,Allarity Therapeutics, Inc.、Aptevo Therapeutics Inc.、Context Therapeutics Inc.较为活跃,换手率分别为2075.16%、332.63%、95.11%,振幅较大的相关个股有Allarity Therapeutics, Inc.、Zura Bio Limited C/Wts 、Cassava Sciences Inc C/Wts 15/11/2024,振幅分别为65.69%、22.07%、21.42%。Glycomimetics, Inc.公司简介:GlycoMimetics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405022141597a57ec9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405022141597a57ec9a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431147860","title":"Glycomimetics, Inc.盘中异动 大幅上涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431147860","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431147860?lang=zh_cn&edition=full","pubTime":"2024-04-29 22:44","pubTimestamp":1714401862,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日22时44分,Glycomimetics, Inc.股票出现波动,股价快速拉升5.18%。截至发稿,该股报1.73美元/股,成交量16.2168万股,换手率0.25%,振幅5.79%。Glycomimetics, Inc.股票所在的生物技术行业中,整体涨幅为0.64%。其相关个股中,Nkgen Biotech Inc C/Wts 31/05/2028、Soleno Therapeutics, Inc.、Ginkgo Bioworks Holdings, Inc.涨幅较大,Zyversa Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Avenue Therapeutics, Inc.较为活跃,换手率分别为925.02%、38.45%、19.58%,振幅较大的相关个股有Annovis Bio, Inc.、Cassava Sciences Inc C/Wts 15/11/2024、Ginkgo Bioworks Holdings, Inc.,振幅分别为33.93%、33.33%、31.39%。Glycomimetics, Inc.公司简介:GlycoMimetics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292244227924f85a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292244227924f85a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429921632","title":"Glycomimetics, Inc.盘中异动 早盘大幅上涨5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429921632","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429921632?lang=zh_cn&edition=full","pubTime":"2024-04-22 21:33","pubTimestamp":1713792787,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日21时33分,Glycomimetics, Inc.股票出现异动,股价快速上涨5.37%。截至发稿,该股报2.03美元/股,成交量4.0962万股,换手率0.06%,振幅4.16%。Glycomimetics, Inc.股票所在的生物技术行业中,整体涨幅为0.44%。其相关个股中,Moolec Science Sa C/Wts 、Moolec Science Sa、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大,Moolec Science Sa、Adial Pharmaceuticals, Inc、亚狮康药业较为活跃,换手率分别为90.55%、44.65%、33.95%,振幅较大的相关个股有Moolec Science Sa C/Wts 、Moolec Science Sa、Nkgen Biotech, Inc.,振幅分别为86.63%、20.71%、15.37%。Glycomimetics, Inc.公司简介:GlycoMimetics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222133087a5491f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222133087a5491f2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428462565","title":"Glycomimetics, Inc.盘中异动 下午盘大幅跳水5.04%报2.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428462565","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428462565?lang=zh_cn&edition=full","pubTime":"2024-04-19 03:01","pubTimestamp":1713466872,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日03时01分,Glycomimetics, Inc.股票出现异动,股价急速下跌5.04%。截至发稿,该股报2.17美元/股,成交量70.3652万股,换手率1.09%,振幅8.23%。Glycomimetics, Inc.股票所在的生物技术行业中,整体跌幅为0.68%。其相关个股中,Artelo Biosciences Inc C/Wts 20/06/2024 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Clene Inc C/Wts 30/12/2025 涨幅较大,Bio-Path Holdings, Inc.、Benitec Biopharma Inc.、Soligenix, Inc.较为活跃,换手率分别为10695.01%、112.65%、51.38%,振幅较大的相关个股有Bio-Path Holdings, Inc.、Artelo Biosciences Inc C/Wts 20/06/2024 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ,振幅分别为126.85%、75.31%、73.93%。Glycomimetics, Inc.公司简介:GlycoMimetics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190301127a53d1ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190301127a53d1ca&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428027938","title":"Glycomimetics, Inc.盘中异动 急速下挫5.10%报2.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428027938","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428027938?lang=zh_cn&edition=full","pubTime":"2024-04-17 03:58","pubTimestamp":1713297502,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日03时58分,Glycomimetics, Inc.股票出现异动,股价快速跳水5.10%。截至发稿,该股报2.14美元/股,成交量57.2109万股,换手率0.89%,振幅8.43%。Glycomimetics, Inc.股票所在的生物技术行业中,整体跌幅为0.66%。其相关个股中,Apollomics Inc C/Wts 01/04/2028 、Jaguar Health, Inc.、Kineta, Inc.涨幅较大,Palisade Bio, Inc.、Longeveron Inc.、Jaguar Health, Inc.较为活跃,换手率分别为3379.40%、293.20%、216.19%,振幅较大的相关个股有Palisade Bio, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Jaguar Health, Inc.,振幅分别为103.61%、101.94%、97.81%。Glycomimetics, Inc.公司简介:GlycoMimetics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404170358227a533322&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404170358227a533322&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427881829","title":"Glycomimetics, Inc.盘中异动 下午盘急速跳水5.00%报2.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427881829","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427881829?lang=zh_cn&edition=full","pubTime":"2024-04-16 01:22","pubTimestamp":1713201748,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日01时22分,Glycomimetics, Inc.股票出现波动,股价快速下挫5.00%。截至发稿,该股报2.28美元/股,成交量43.767万股,换手率0.68%,振幅6.46%。Glycomimetics, Inc.股票所在的生物技术行业中,整体跌幅为0.06%。其相关个股中,Cingulate Inc C/Wts 10/12/2026 、安皮奥制药、Longeveron Inc.涨幅较大,Longeveron Inc.、Soligenix, Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为1499.91%、1210.56%、840.09%,振幅较大的相关个股有安皮奥制药、Soligenix, Inc.、Cassava Sciences Inc C/Wts 15/11/2024,振幅分别为273.33%、114.53%、80.04%。Glycomimetics, Inc.公司简介:GlycoMimetics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041601222987e80829&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041601222987e80829&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.glycomimetics.com","stockEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":-0.8327},{"period":"3month","weight":-0.91},{"period":"6month","weight":-0.8424},{"period":"1year","weight":-0.8589},{"period":"ytd","weight":-0.8852}],"compareEarnings":[{"period":"1week","weight":-0.0039},{"period":"1month","weight":0.054},{"period":"3month","weight":0.0283},{"period":"6month","weight":0.1487},{"period":"1year","weight":0.2502},{"period":"ytd","weight":0.1095}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Glycomimetics, Inc.作为一家临床生物科技公司,致力于发现并开发新型拟糖物药物以解决某些疾病引起的未曾遇到的医疗需求,而碳水化合物生物技术在此类疾病中扮演关键角色。拟糖物是一簇分子,这些分子能够模仿重要生物程序中碳水化合物的结构。利用其在碳水化合物化学及碳水化合物生物领域的专业知识,公司正在开发一系列其自主所有的拟糖物,这些拟糖物能够抑制碳水化合物疾病化的功能,如在炎症反应,癌症以及传染病中的功能。公司相信这代表药物发现以治疗众多疾病的一个创新性方法。公司2003年4月4日注册成立并于2003年5月21日开始运营。公司总部设在马里兰州的盖瑟斯堡。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.013308},{"month":2,"riseRate":0.545455,"avgChangeRate":-0.018157},{"month":3,"riseRate":0.363636,"avgChangeRate":-0.038199},{"month":4,"riseRate":0.363636,"avgChangeRate":-0.08747},{"month":5,"riseRate":0.545455,"avgChangeRate":0.115769},{"month":6,"riseRate":0.3,"avgChangeRate":-0.008211},{"month":7,"riseRate":0.4,"avgChangeRate":-0.023807},{"month":8,"riseRate":0.4,"avgChangeRate":-0.061372},{"month":9,"riseRate":0.2,"avgChangeRate":-0.048353},{"month":10,"riseRate":0.4,"avgChangeRate":-0.018479},{"month":11,"riseRate":0.8,"avgChangeRate":0.344795},{"month":12,"riseRate":0.3,"avgChangeRate":0.013158}],"exchange":"NASDAQ","name":"GlycoMimetics Inc.","nameEN":"GlycoMimetics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.5","shortVersion":"4.22.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GlycoMimetics Inc.(GLYC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供GlycoMimetics Inc.(GLYC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"GlycoMimetics Inc.,GLYC,GlycoMimetics Inc.股票,GlycoMimetics Inc.股票老虎,GlycoMimetics Inc.股票老虎国际,GlycoMimetics Inc.行情,GlycoMimetics Inc.股票行情,GlycoMimetics Inc.股价,GlycoMimetics Inc.股市,GlycoMimetics Inc.股票价格,GlycoMimetics Inc.股票交易,GlycoMimetics Inc.股票购买,GlycoMimetics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GlycoMimetics Inc.(GLYC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供GlycoMimetics Inc.(GLYC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}